TNF and cancer: Infliximab, anti-TNFα monoclonal antibody, was applied to treat cancer-related cachexia in subjects with pancreatic cancer in clinical phase II (Wiedenmann et al., 2008; Arruda et al., 2010; Gueta et al., 2010; Miksza et al., 2013).